NASDAQ: AXLA - Axcella Health Inc.

Lønnsomhet i seks måneder: +1 042.43%
Sektor: Healthcare

Kampanjeplan Axcella Health Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet

Axcella Health Inc. operates as a clinical-stage biotechnology company in the United States. The company treats complex diseases using endogenous metabolic modulators. Its product pipeline includes AXA1125 that is in Phase 2a clinical trial for long COVID therapy for patients, as well as Phase 2b clinical trial for treating non-alcoholic steatohepatitis; and AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016.

Flere detaljer
Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

EBITDA -0.0328
EV/EBITDA 1.67
IPO date 2019-05-09
ISIN US05454B1052
Industry Biotechnology
P/BV 27.05
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.axcellahealth.com
Цена ао 0.4009
Prisendring per dag: +1 042.43% (0.4009)
Prisendring per uke: +1 042.43% (0.4009)
Prisendring per måned: +1 042.43% (0.4009)
Prisendring over 3 måneder: +1 042.43% (0.4009)
Prisendring over seks måneder: +1 042.43% (0.4009)
Prisendring per år: -56.05% (10.42)
Prisendring over 3 år: +41.8% (3.23)
Prisendring over 5 år: -41.21% (7.79)
Prisendring siden begynnelsen av året: -55.96% (10.4)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
Total: 2.5

Effektivitet

Navn Betydning Karakter
ROA, % 0 0
ROE, % 0 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA 0 10
Total: 10

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 0 0
Lønnsomhet Ebitda, % 91.45 9
Lønnsomhet EPS, % -97.23 0
Total: 5.8
Flere detaljer

Institusjoner Volum Dele, %
Flagship Pioneering Inc. 1170059 39.69
Harbourvest Partners, LLC 248317 8.42
Schonfeld Strategic Advisors LLC 100600 3.41
FMR, LLC 66455 2.25
Vanguard Group Inc 32034 1.09
Geode Capital Management, LLC 11022 0.37
Blackrock Inc. 9903 0.34
Tower Research Capital LLC (TRC) 1225 0.04
JP Morgan Chase & Company 1073 0.04
Morgan Stanley 1004 0.03



Veileder Stillingstittel Betaling Fødselsår
Dr. Alison D. Schecter M.D. Pres of Strategy & Operations 525.53k 1964 (60 år)
Mr. David R. Epstein B.Sc., M.B.A. Consultant 228.34k 1962 (62 år)
Mr. Dan Kirby Sr. VP of Strategic Operations N/A
Mr. William R. Hinshaw Jr. Pres, CEO & Director 1969 (55 år)
Mr. Laurent Chardonnet Consultant 1965 (59 år)
Mr. Robert W. Crane Sr. VP & CFO 1959 (65 år)
Dr. Paul Fehlner J.D., Ph.D. Sr. VP, Chief Legal Officer & Corp. Sec. 1964 (60 år)
Ms. Virginia R. Dean Sr. VP & Chief People Officer 1966 (58 år)
Dr. Larry Bell Global Head of Regulatory Affairs & Pharmacovigilance and Sr. VP
Dr. Margaret James Koziel M.D. Sr. VP & Chief Medical Officer 1960 (64 år)

Adresse: United States, Cambridge. MA, 840 Memorial Drive - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.axcellahealth.com